Publication

Biomarkers for cellular senescence

Demaria, M., 13-Sep-2018, Patent No. WO2018164580, Priority date 9-Mar-2017

Research output: PatentProfessional

APA

Demaria, M. (2018). Biomarkers for cellular senescence. (Patent No. WO2018164580).

Author

Demaria, Marco (Inventor). / Biomarkers for cellular senescence. Patent No.: WO2018164580.

Harvard

Demaria, M 2018, Biomarkers for cellular senescence, Patent No. WO2018164580.

Standard

Biomarkers for cellular senescence. / Demaria, Marco (Inventor).

Patent No.: WO2018164580.

Research output: PatentProfessional

Vancouver

Demaria M, inventor. Biomarkers for cellular senescence. WO2018164580. 2018 Sep 13.


BibTeX

@misc{977b22a1d89442c3bbfdbd7ce9c00f4a,
title = "Biomarkers for cellular senescence",
abstract = "The invention relates to biomarkers and uses thereof, in particular to a set of proteins or mRNAs that provides a significant indication as to whether a cell is senescent or not. Provided is the use of a biomarker panel comprising six or more polypeptides, or their encoding mRNA's, wherein the panel comprises at least the biomarkers TSPAN13, GDNF, C2CD5, SUSD6, BCL2L2, PLK3, or a variant or fragment thereof, as a biomarker set for cellular senescence. Also provided is a senescent cell detection kit for detecting senescent cells, and a drug conjugate for killing a senescent cell.",
author = "Marco Demaria",
year = "2018",
month = "9",
day = "13",
language = "English",
type = "Patent",
note = "WO2018164580",

}

RIS

TY - PAT

T1 - Biomarkers for cellular senescence

AU - Demaria, Marco

PY - 2018/9/13

Y1 - 2018/9/13

N2 - The invention relates to biomarkers and uses thereof, in particular to a set of proteins or mRNAs that provides a significant indication as to whether a cell is senescent or not. Provided is the use of a biomarker panel comprising six or more polypeptides, or their encoding mRNA's, wherein the panel comprises at least the biomarkers TSPAN13, GDNF, C2CD5, SUSD6, BCL2L2, PLK3, or a variant or fragment thereof, as a biomarker set for cellular senescence. Also provided is a senescent cell detection kit for detecting senescent cells, and a drug conjugate for killing a senescent cell.

AB - The invention relates to biomarkers and uses thereof, in particular to a set of proteins or mRNAs that provides a significant indication as to whether a cell is senescent or not. Provided is the use of a biomarker panel comprising six or more polypeptides, or their encoding mRNA's, wherein the panel comprises at least the biomarkers TSPAN13, GDNF, C2CD5, SUSD6, BCL2L2, PLK3, or a variant or fragment thereof, as a biomarker set for cellular senescence. Also provided is a senescent cell detection kit for detecting senescent cells, and a drug conjugate for killing a senescent cell.

M3 - Patent

M1 - WO2018164580

ER -

ID: 66479560